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The density of immunoglobulin  (Ig) on the surface of mouse bone marrow- 
derived (B) lymphocytes has recently been studied by two groups of investiga- 
tors  (1-3).  Both groups attributed developmental significance to differences in 
the density of Ig on the surface of these cells, but Osmond and Nossal concluded 
that a substantially greater heterogeneity in the amount of Ig per B cell existed 
in the  immature  population  vs.  the  mature  population,  whereas Sidman  and 
Unanue  indicated  that  immature  cells  have,  on  the  average,  more  Ig  than 
mature cells. The techniques employed in these studies are very tedious and are, 
therefore, poorly suited to a detailed analysis of the distribution of the density of 
surface Ig on different populations of B  lymphocytes. However, the density of 
surface Ig on individual B lymphocytes derived from different sources is critical 
to the understanding  of antigen-B-lymphocyte interaction  and activation.  The 
introduction  of the  technique  of rapid  flow  microfluorometry  (RFMF) ~ and 
electronic cell sorting makes possible a direct approach to the study of surface Ig 
density on B lymphocytes and to an evaluation of its developmental and func- 
tional significance. 
Using  this  technology,  we  report  here  the  identification  among  splenic  B 
lymphocytes of a  large  subpopulation  of cells possessing  a  relatively  low-to- 
intermediate  density  of surface  Ig  when  a  fluorescein-conjugated  (F1) anti- 
mouse Ig or anti-K  is used to detect Ig-bearing cells.  Such B  lymphocytes, as 
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detected by a peak in the fluorescence  profile, are found in the spleen and lymph 
nodes of adult mice.  A  similar peak  is not detected  when neonatal spleen or 
adult bone marrow cells are examined. The development of this population of B 
lymphocytes occurs during the first 4 wk of life and appears to be independent of 
the influence  of thymus-derived  (T)  lymphocytes or of antigenic  stimulation, 
since the fluorescence profiles of spleen cells of adult congenitally athymic (nu/ 
nu) mice and of mice raised under germfree  conditions are indistinguishable 
from those of normal adult animals. Parallel studies using F1 anti-~ to identify 
surface IgM failed to demonstrate the distinct B-lymphocyte subpopulation with 
low-to-intermediate fluorescence intensity among adult spleen cells. Moreover, 
the  fluorescence  profiles  of F1  anti-~-labeled  adult  bone  marrow  and  adult 
spleen were similar to each other. 
Materials and Methods 
Animals.  DBA/2N,  C57BL/6N,  and  BALB/cAnN  (germfree or conventionally reared)  mice 
were obtained from the Animal Production Section, Division of Research Services of the National 
Institutes of Health, Bethesda, Md. CBA/J and C3H/HeJ mice were purchased from The Jackson 
Laboratory, Bar Harbor, Maine. BALB/c nu/nu and +/nu littermates which were in the seventh 
backcross generation were obtained from the Charles River Breeding Laboratories, Inc., Wilming- 
ton, Mass.  Mice were from 8 to 12 wk of age at the time of study unless otherwise noted. In all 
instances, lymphoid organs from individual mice were studied, except when newborn to 3-wk-old 
mice were analyzed, when the lymphoid organs of four to five individual mice were pooled. 
Cell Suspensions.  Spleens; Peyer's patches; popliteal, inguinal, and cervical lymph nodes; and 
tibiae and fibulae were obtained from mice killed by cervical dislocation. Suspensions of spleen, 
Peyer's patches, and lymph node cells were prepared by teasing of these organs with forceps into 
RPMI  1640  (Grand Island Biological  Co.,  Grand Island,  N.  Y.)  while bone marrow cells were 
flushed from the shaft of the tibia or fibula using a 25 gauge needle and syringe. Cell aggregates 
were  dispersed  by  passage  through  a  26  gauge  needle.  Spleen  and  bone  marrow  cells  were 
centrifuged at 100g for 10 min, the supernatant fluid removed, and the pellet treated with 5 ml of 
0.83% ammonium chloride at 4°C for 5 rain to lyse red blood cells. Nucleated cells obtained by this 
method were washed through fetal calf serum (FCS) (Grand Island Biological Co.) to remove red 
blood cell ghosts. 
Anti-Immunoglobulin  Reagents.  A  polyspecific  goat  anti-mouse  7S  globulin  and  an  anti- 
mouse-/z were obtained from Meloy Laboratories Inc., Springfield, Va. (Lot nos. 40691 and 40643, 
respectively). These antisera were digested with 2% (wt/wt) pepsin (Mann Research Labs, New 
York)  in  acetate  buffer  (pH  4.0)  for  18  h,  and  F(ab')2  fragments  were  further  purified  on  a 
Sephadex  G-200  column  (100  x  1  cm),  dialyzed  against  a  bicarbonate  buffer  (pH  9.3),  and 
concentrated to 4 mg/ml. F(ab')2 fragments were conjugated with fluorescein isothiocyanate (BBL, 
Division of Becton, Dickinson & Co., Cockeysville, Md.) by overnight dialysis of 10 ml of protein 
(10 mg) in a bicarbonate buffer (pH 9) against 1 mg of FITC in 1 ml of the buffer enclosed within a 
dialysis bag. F1 F(ab')2 antisera with a  molar ratio of protein to fluorescein of approximately 2:1 
were  isolated  from  proteins  with  a  higher or  lower  protein-to-fluorescein ratio  using  DEAE- 
cellulose column chromatography. The F1 F(ab')2 anti-Ig and anti-/z will be referred to as the F1 
anti-Ig and F1 anti-/~, respectively. In addition to these preparations, a  series of fluoresceinated 
affinity column-purified antibodies was also used in these studies. These include goat anti-mouse 
Y~-, y2-, a-, and/z-antibodies (4) and rabbit anti-mouse-K antibody (a gift from Dr. R. Mage, NIH, 
Bethesda, Md.). 
In order to further analyze the specificity of the F1 anti-Ig, 0.8 mg (0.2 ml) of this reagent was 
passed through a  1 ml column containing 200/zg each of IgGj(K), IgG~a(K), and IgG2b(K) myeloma 
proteins bound to Sepharose. The column was eluted with 5 cm  3 of borate buffer and the effluent 
was dialyzed against saline and concentrated to the original protein concentration. The molar 
ratio of protein to fluorescein of this material was similar to that of the original. As noted in the 
Results section, absorption of the anti-Ig with these three mouse myeloma proteins abolished the 
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Lymphocyte Staining.  Nucleated  cells  obtained from lymph node  or ammonium chloride- 
treated bone marrow or spleen cell suspensions were washed twice with RPMI 1640 and adjusted to 
50 x  106 cells/ml with RPMI 1640 containing 5% FCS and 1 mg/ml of sodium azide. Preliminary 
studies  indicated  that  10  x  106 cells  in  200  ~tl would be optimally labeled  for use with  the 
Fluorescence Activated Cell Sorter (FACS) (Becten, Dickinson Electronics Laboratory, Mountain 
View, Calif.) with 20 ug of F1 anti-Ig; 10/~g of F1 anti-u; or 2.5 #g of the affinity column purified 
anti-/~, anti-K, anti-y1, anti-T2, and anti-a. The undigested  Fl antibodies  (anti-K, anti-N,  anti-y1, 
anti-y2, and anti-a) were ultracentrifuged for 40 rain at 100,000 g before their use. Cell suspensions 
were incubated with F1 antibodies  at 4°C for 30 min, washed three times in cold RPMI 1640 (5% 
FCS, 1 mg/ml sodium azide), and resuspended  in the same media to 10 x 106 cells/ml. 
Flow Microfluorometry.  A detailed explanation of the principle of RFMF has been presented 
by Loken and Herzenberg (5). The frequency  and fluorescence  profile  of cells stained with F1 
antisera was determined after examining at least  100,000 viable cells,  Cellular volume was 
determined by a Coulter Counter (Model B; Coulter Electronics  Inc., Hialeah, Fla.) which was 
made available by Dr. C. Herman, NIH, Bethesda, Md. 
Results 
Fluorescence Profile of Murine Lymphocytes Stained with Fl Anti-Ig.  The 
fluorescence  profiles  of unstained  and  F1  anti-Ig-stained  CBA/J  thymus  and 
spleen cells are shown in Figs.  1 a  and b.  The horizontal  axis of these  and all 
subsequent  fluorescence  profiles  displays  1,000  linear  channels  of increasing 
fluorescence  intensity  toward  the  right,  while  the  vertical  axis  displays  the 
number  of individual  cells  within  each  channel.  Less  than  0.2%  of CBA/J 
thymus cells were stained by the F1 anti-Ig, indicating that this reagent was not 
detecting  species-specific  surface  antigens  found  on  mouse  thymocytes.  By 
contrast, when CBA/J splenic lymphocytes stained with F1 anti-Ig were studied 
by  RFMF,  54.5%  of the  cells  were  found  to  be  fluorescent.  The  fluorescence 
profile of these F1 anti-Ig-stained splenic B lymphocytes was characterized by a 
large  peak  of  cells  which  has  a  low-to-intermediate  degree  of fluorescence 
intensity.  Similar fluorescence profiles were obtained when DBA/2N  (Fig. 2a), 
C57BL/6, BALB/c, and C3H/HeJ splenic lymphocytes were stained with F1 anti- 
Ig.  Thus,  the  existence of a  large  number of cells with  a  low-to-intermediate 
degree of fluorescence intensity as a dominant feature of the fluorescence profile 
of adult  splenic  B  lymphocytes appears to be a  general  phenomenon,  as  it is 
found in spleen cells from five different inbred mouse strains. 
In order to further characterize the F1 anti-Ig, we stained C57BL/6 spleen cells 
with  this  reagent  and  compared the  profile  to  that  of C57BL/6  stained  cells 
stained with F1 anti-K. The fluorescence profiles of these cells after labeling with 
either F1  anti-Ig or F1  anti-K were virtually identical  and the frequency of Ig- 
positive cells were 44.7  and 46.5%,  respectively.  Moreover,  after absorption of 
the F1 anti-Ig on a  Sepharose column containing IgG1, IgG2a, and IgG2b mouse 
myeloma  proteins,  as  described  in  the  Materials  and  Methods  section,  its 
capacity to label splenic B  lymphocytes was abolished. 
The large number of splenic B  lymphocytes displaying a  low-to-intermediate 
degree of fluorescence after staining with F1 anti-Ig could be accounted for by (a) 
the presence of cells of a  uniform volume which contained a major population of 
cells with a  low-to-intermediate density of surface Ig,  (b) the presence of cells 
with a  uniform density of surface Ig which contains a  large population of cells 
with a low-to-intermediate cellular volume, or (c) populations of cells varying in SCHER,  SHARROW,  WISTAR,  ASOFSKY,  AND  PAUL  497 
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FiG.  l.  Fluorescence profiles of (e) CBA/J thymus cells, unlabeled (---) or labeled with FI 
anti-Ig (--);  (b) CBA/J spleen cells,  unlabeled (---) or labeled with F1 anti-Ig (--). 
FIG.  2.  Fluorescence  profiles of (a) DBA/2 spleen cells labeled with F1 anti-Ig,  (b) DBA/2 
spleen  cells labeled  with F1 anti-Ig and separated  according  to their relative fluorescence 
intensity  as noted by the arrows,  and  (c) DBA/2 spleen cells labeled with F1 anti-Ig after 
separation.  Fig.  3 c  is a  composite  picture of individual  analytical  runs of cells that were 
separated as shown  in Fig.  3 b. 
their volume and density of surface Igo In order to distinguish between these 
possibilities, spleen cells from DBA/2N mice were stained with F1 anti-Ig (Fig. 
2a) and cells with low fluorescence intensity were separated from those with 
high fluorescence intensity using the FACS (Fig. 2 b). When these cells were re- 498  B-LYMPHOCYTE  HETEROGENEITY 
examined with the FACS, the separation of low from high intensity fluorescence 
cells was confirmed (Fig. 2 c). The average cellular volumes of these two popula- 
tions were 119 and 128 ~m  3 for the "bright" and low-to-intermediate fluorescence 
intensity B lymphocytes, respectively. This indicates that the distinct fluores- 
cence intensities  of these two populations does not reflect differences in their 
cellular volumes, but is secondary to differences in the density of Ig on their 
surfaces. 
Fluorescence Profiles of Bone Marrow, Lymph Node, or Peyer's Patch Lym- 
phocytes  Stained  with Fl anti-K.  The  fluorescence profiles of bone marrow, 
lymph node, and Peyer's patch lymphocytes stained with F1 anti-K are shown in 
Figs.  3a-c,  respectively. In order to facilitate the comparison of these profiles 
with those obtained with splenic lymphocytes, the scale  (counts  ×  100) of the 
bone marrow,  lymph  node,  and  Peyer's patch  plots was changed  so that  the 
areas under the Ig-positive portion of the curves (channels 80-1,000) would equal 
that  of the  splenic  profile  and  the  two  profiles  were  plotted  together.  The 
frequency of Ig-positive  cells  in  the  bone marrow,  lymph nodes,  and  Peyer's 
patches  was  18.9,  18.4,  and  55.2%,  respectively.  B  lymphocytes derived from 
CBA/J lymph nodes (Fig. 3 b) had a fluorescence profile which was very similar 
to the profile of splenic B lymphocytes. The profile obtained with Peyer's patch 
cells (Fig.  3c) demonstrates that  a  large fraction of the cells have a  very low 
fluorescence intensity  and are poorly separated from background.  No fluores- 
cence peak was seen when bone marrow  cells  (Fig.  3a)  were labeled with F1 
anti-K.  Moreover, there were substantial  numbers of very intensely stained B 
lymphocytes in bone marrow,  and the relative frequency of bright cells in this 
organ was greater than in spleen. 
Fluorescence Profile of Neonatal Spleen Cells Stained with Fl Anti-Ig.  The 
absence of the fluorescence peak among bone marrow cells stained with F1 anti- 
Ig suggested that  the  cells within  the  low-to-intermediate  fluorescence peak 
seen  in  the  spleens  and  lymph  nodes  of adult  mice  represented  a  mature 
subpopulation  of B  lymphocytes.  This  was further  studied by examining  the 
fluorescence profile of spleen cells derived from 3-,  10-,  17-, and 30-day-old and 
adult  BALB/c  mice  (Figs.  4a-e).  In  the  first  17  days  of life,  the  relative 
frequency of cells with a very low-to-low (channels 80-200) and low-to-intermedi- 
ate (channels 200-400) fluorescence intensity among the Ig-positive cells (chan- 
nels 80-1,000) increases so that at 17 days they represent 44.2 and 42.1% of the 
Ig-positive  cells,  respectively  (Table  I).  These  changes  are  associated  with  a 
marked  increase  in  the  overall  frequency of Ig-positive  cells  (29.2  to  54.0%). 
After 17 days, the frequency of cells with a  very low-to-low fluorescence inten- 
sity begins to decrease and the continued decline in this population associated 
with an  increase in the relative frequency of cells with a  low-to-intermediate 
fluorescence intensity results in the characteristic F1 anti-Ig-labeled adult pro- 
file (Fig. 4 e). 
Fluorescence Profiles of nu/nu and Germfree BALB/c Splenic B Lymphocytes 
Stained with Fl Anti-Ig.  After labeling with F1 anti-Ig, the fluorescence profile 
and frequency of Ig-positive cells among spleen cells derived from convention- 
ally or germfree-reared adult BALB/c mice were essentially identical (data not 
shown). The fluorescence patterns of nu/nu and  +/nu spleen cells labeled with 5 
0 i 
X 
cO 
~4 
O 
SCHER,  SHARROW,  WISTAR,  ASOFSKY,  AND  PAUL 
F luorescence 
1.3 
(3 
0.98 
,~,~  Io.65 
I  I  I  I  I  I  I  I  I  - 
fl  c  t:  .8  3  i  ¸:~  .8 
i  i 
2  !' ' i~"i~'.,:  ,I.9 
b  ,-, 
3  0.85 
t '! 
0.57 
200  400  600  800  I000 
499 
0 
ChQnnel  number 
Fia.  3.  Fluorescence  profiles of (a--e) CBA/J  spleen  cells labeled  with F1 anti.Ig  (--) 
compared to (a) CBA/J bone marrow cells (--), (b) CBA/J lymph node cells (---), and (e) 
CBAIJ Peyer's patch cells (---), labeled with F1 anti-Ig.  The profiles of the bone marrow, 
lymph node, and Peyer's patch cells were plotted so that the areas under the Ig-positive 
portion of their fluorescence profiles were equal to that of the spleen cell profile. 
F1 anti-Ig were also similar to each other and to that of normal adult cells (Fig. 
5).  However,  the  frequency of Ig-positive  cells  in  BALB/c nu/nu  spleen  cell 
suspensions was considerably greater (87.1%) than seen with the +/nu spleens 
(5O.6%). 
Fluorescence  Profiles  of Lymphocytes  Stained  with  Fl Anti-Heavy  Chain 
Antibodies. The frequency of fluorescent cells after labeling adult CBA/J spleen 
cells with F1 anti-Ti, F1 anti-72, F1 anti-a, and F1 anti-g was  <1,  3.8,  <1,  and 
54.0%, respectively. Although the F1 anti-g stained an equivalent percentage of 
spleen cells when compared to F1 anti-K (54 vs. 54.1%), a fluorescence peak was 
not seen after labeling with F1 anti-g  (Fig. 6a). 
When  B  lymphocytes  from  CBA/J  adult  bone  marrow,  lymph  node,  and 
Peyer's patches were stained with F1 anti-g,  the profiles obtained were gener- 
ally similar to each other and to those observed with adult spleen cells (Figs. 
6b-d).  In  no  case,  was  a  low-to-intermediate  intensity fluorescence peak  ob- 
served. However, the relative frequency of cells with a very low-to-intermediate 
density of surface IgM among the Ig-positive cells was greater in lymph node 
and Peyer's patches (86.0 and 89.4%, respectively) than spleen and bone marrow 
(74.2  and  71.7%,  respectively).  The frequency of Ig-positive  lymphocytes,  de- 
tected after labeling with F1 anti-g, was 19.8, 16.6, and 33.8% when cells derived 500 
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FIG.  4.  Fluorescence profiles of BALB/c spleen cells labeled with F1 anti-lg from (a) 3-day- 
old, (b) 10-day-old,  (c) 17-day-old,  (d) 30-day-old,  and (e) adult mice. 
from CBA/J,  bone marrow,  lymph  nodes,  or Peyer's patches  were examined. 
These data are similar to that obtained when the cells from these organs were 
labeled with F1 anti-Ig, as noted above, except in the case of Peyer's patch cells, 
where F1 anti-K  labels 21.4% more cells than F1 anti-~t. 
Finally, the fluorescence profiles of F1 anti-~-labeled spleen cells from 3-, 10-, 
17-,  and  30-day-old  and  adult  BALB/c  mice  are  shown  in  Figs.  7a-e.  These 
profiles  are  similar  to  one  another  in  that  they  lack  a  fluorescence  peak. 
However, the relative frequency of cells with a very low-to-intermediate fluores- 
cence intensity among the positive cells increases considerably from 51.3% at 3 
days  to  67.2%  at  17  days  (Table  II).  The  increase  in this  population  of cells SCHER,  SHARROW,  WISTAR,  ASOFSKY,  AND  PAUL  501 
TABLE  I 
Frequency of Ig-Positive Lymphocytes Among BALB/c Spleen Cells Labeled with Fl 
Anti-Ig 
Figure  Age  Ig-positive cells 
Frequency of cells, among the Ig-posi- 
tive population, with a fluorescence in- 
tensity of: 
80-200*  200-400* 
days  % 
4a  3  29.2  39.9  36.6 
4b  10  34.8  42.8  40.7 
4c  17  54.0  44.2  42.1 
4d  30  49.7  36.5  43.0 
4e  Adult  44.0  23.2  50.8 
* FI  anti-Ig-labeled  lymphocytes  appearing  in  channels  80-200  and  200-400  are  designated  as 
having a  very-low density and low-to-intermediate  density of surface Ig. 
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FIG.  5.  Fluorescence  profiles of spleen  cells labeled  with F1 anti-Ig from  +/nu  BALB/c 
(--), or nu/nu BALB/c (---) mice. 
continues so that at 30 days of age these cells represent 73.4% of the total surface 
IgM-positive population, which is similar to the frequency of these cells in the 
spleen cells of adults (Fig. 7e). Thus, as B lymphocytes mature in the spleens of 
neonatal mice, the relative density of their surface IgM decreases. 
Discussion 
In  this  study,  we  have  utilized  the  technology  of RFMF  to  determine  the 
relative density of surface Ig on B lymphocytes derived from different lymphoid 
organs of adult mice and from the spleens of neonatal mice in different stages of 
their maturation.  Splenic  B  lymphocytes derived from adult DBA/2,  BALB/c, 
CBA/J, C57BL/6, and C3H/J mice labeled with either F1 anti-Ig or F1 anti-K had 
a  fluorescence  profile which was characterized  by a  large  peak of cells with a 
relatively homogenous intensity of fluorescence. The cells within this peak have 502  B-LYMPHOCYTE  HETEROGENEITY 
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Fro. 6.  Fluorescence  profiles of (a) CBA/J spleen cells unlabeled (---) or labeled with FI 
anti-~ (--), (b) CBA/J bone marrow cells unlabeled (---) or labeled with F1 anti-p (--), (c) 
CBA/J lymph node cells unlabeled (---) or labeled with F1 anti-~ (--), and (d) CBA/J Peyer's 
patch cells unlabeled (---) or labeled with F1 anti-~ (--). 
a  low-to-intermediate density of total  surface  Ig.  Moreover,  since  F1  anti-T2 
antibody labeled  only 3.8%  of splenic  lymphocytes, it  is  unlikely that  cells 
bearing passively acquired cytophilic antibody of the IgG2  class contribute to 
any extent to this peak. The characteristic profile observed after labeling adult 
spleen cells with Fl anti-Ig was also seen when adult spleen cells derived from 
either nu/nu  mice or from mice reared under germfree conditions were exam- 
ined. Thus, the development of the large, relatively homogenous population of 
splenic B lymphocytes, which have a low-to-intermediate density of surface Ig, 
appears  to  be  independent  of either  antigenic  stimulation  or  T-lymphocyte 
cooperation. Moreover, the absence of  the low-to-intermediate fluorescence peak 
among adult bone marrow cells and neonatal spleen cells and its presence in 
adult spleen and lymph node cells suggest that the cells with a low-to-intermedi- 
ate density of surface Ig represent a distinct, mature subclass of B lymphocytes. 
The fluorescence profiles of F1 anti-/~-labeled cells derived from adult mouse 
bone marrow, adult spleen, or neonatal spleen lacked the peak seen when F1 
anti-Ig-labeled adult spleen cells were examined. Nonetheless, a clear difference 
in the fluorescence profiles of F1 anti-/~-labeled adult and neonatal spleen was 
noted. On the other hand, the F1 anti-~ profiles of adult bone marrow and adult 
spleen were not distinguishable.  Thus, the relative immaturity of adult bone 2,3- 
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Fro.  7.  Fluorescence profiles of BALB/c spleen cells labeled with FI anti-~ from (a) 3-day- 
old, (b) 10-day-old,  (c)  17-day-old,  (d) 33-day-old,  and (e) adult mice. 
marrow cells, which is observed aider comparing the fluorescence profiles of F1 
anti-Ig-labeled  adult bone marrow and adult spleen cells,  is not detected when 
such cells are labeled with F1 anti-~. 
The frequency of IgM-bearing B lymphocytes within the spleen, lymph node, 
and bone marrow of mice is similar to the frequency of cells from these lymphoid 
organs  detected  by  F1 anti-Ig  or F1 anti-K.  Other authors  using  conventional 
fluorescence microscopy have reported that the frequency of IgM-bearing lym- 
phocytes is substantially  less than that of Ig-bearing  B  lymphocytes  in these 
organs (6).  This apparent discrepancy is most likely explained by the ability of 
the FACS to detect those cells with a level of fluorescence which is just above 504  B-LYMPHOCYTE  HETEROGENEITY 
TABLE II 
Frequency of IgM-Positive Lymphocytes Among Spleen Cells 
from BALB/c Mice Labeled with Anti-~ 
Frequency of  cells, among 
IgM-positive  IgM-positive cells, with a 
Figure  Age  cells  fluorescence intensity of 
80-400* 
days  % 
7a  3  33.6  51.3 
7b  10  35.8  59.2 
7c  17  52.1  67.2 
7d  30  45.1  73.4 
7 e  Adult  42.9  75.7 
* Cells appearing in channels 80-400  are designated as having a very- 
low-to-intermediate density of surface IgM. 
that of unlabeled cells and which might not be detected as Ig-positive cells using 
conventional microscopy. This is not an important problem with F1 anti-Ig- or F1 
anti-K-labeled spleen or lymph node cells because the relative frequency of cells 
with a very low level of fluorescence intensity is quite low. However, such cells 
represent a larger fraction of cells labeled by F1 anti-~.  On the other hand,  we 
did observe a large difference in the frequency of cells labeled by Fl anti-K and by 
F1 anti-~t in Peyer's patch cell suspensions,  as has been previously reported by 
Guy-Grand and his co-workers (7). 
A number of observations suggest that the development of the peak of splenic 
B  lymphocytes is associated with the  acquisition by these cells of the surface 
membrane  protein  which  is  the  putative  homologue  of human  surface  IgD 
(subsequently referred to as IgD)  (8).  The  appearance  of the adult splenic  F1 
anti-Ig-labeled fluorescence profile and of an adult ratio of surface IgM to IgD 
occurs  after  the  first  30  days  of life  and  their  development  is  seen  in  both 
germfree and nu/nu mice. In addition, the differences between the profiles of F1 
anti-Ig-labeled bone marrow and spleen, and the similarities seen after labeling 
these cells with F1 anti-~ can be best explained by the absence of surface IgD on 
the surface of bone marrow cells, as noted by Vitetta et al.  (8). The decrease in 
the fraction of F1 anti-Ig-labeled very-low-to-low fluorescence intensity cells and 
the increase in the frequency of F1 anti-~-labeled very-low-to-low fluorescence 
intensity cells in developing mice is, therefore, most likely due to the acquisition 
of surface IgD by maturing  splenic B  lymphocytes which bear very-low-to-low 
densities of surface IgM. 
It is not clear from our data if a population of B lymphocytes that exclusively 
expresses IgD exists in lymph node or spleen. However, if such a population is 
present in these organs, then it must represent a relatively small fraction of Ig- 
bearing B lymphocytes, as the frequency of IgM-positive cells was only slightly 
less than that of cells detected with F1 anti-Ig. It is possible that a population of 
B  lymphocytes exists with a  relatively high  IgD-to-IgM ratio  but which  still 
bears sufficient IgM to be detected by the FACS. Of course, unanticipated cross- 
reactions between IgM and IgD may exist and may lead to an overestimate of SCHER,  SHARROW,  WISTAR,  ASOFSKY,  AND  PAUL  505 
the  relative  frequency of IgM-bearing  cells.  In  Peyer's patches,  on the  other 
hand,  there may be a  substantial  number of cells which bear IgD only. 
The development of a large population of splenic B lymphocytes with a low-to- 
intermediate density of surface Ig also coincides temporally with the acquisition 
of the antigens responsible for the minor lymphocyte-stimulating  (Mls) mixed 
lymphocyte reactions and the appearance of complement receptor lymphocytes 
(9,  10). These data indicate that the development of Mls-defined antigens,  the 
complement receptor,  surface IgD,  and  large numbers  of lymphocytes with a 
low-to-intermediate density of surface Ig serve as markers of a mature subpopu- 
lation of B lymphocytes. Moreover, they show that the acquisition of immuno- 
competence by B  lymphocytes is not simply a  function of expression of large 
amounts of immunoglobulin on the cell membrane. 
Summary 
The density of total Ig and of IgM, IgGl, IgG2, and IgA on the surface of adult 
murine splenic B lymphocytes was measured using the technique of rapid flow 
microfluorometry.  In addition,  the density of total surface Ig and of IgM on B 
lymphocytes  derived  from  adult  bone  marrow,  lymph  nodes,  and  Peyer's 
patches,  and  from neonatal  spleen was determined.  Adult spleen  and  lymph 
node B lymphocytes are characterized by the presence of a  large population of 
cells with a  low-to-intermediate  density of total surface Ig, which is seen as a 
peak in the fluorescence profiles when these cells are labeled with fluorescein- 
conjugated (F1) anti-Ig. This peak is not detected when neonatal spleen or adult 
bone marrow  are examined;  the development of this peak among spleen cells 
occurs during  the  first 4  wk of life.  Although  the  characteristic  fluorescence 
intensity peak is not seen when adult spleen cells are labeled with F1 anti-~, 
changes in the density of surface IgM do occur during the first few weeks of life 
and are detected as a  decrease in the frequency of cells which have relatively 
large amounts of surface IgM. The differences seen in the fluorescence patterns 
of adult spleen cells labeled with  F1 anti-Ig  and  F1 anti-~  may be due to the 
appearance  of IgD  on  the  surface  of mature  splenic  B  lymphocytes.  This  is 
supported by the similarity  of the fluorescence profiles of adult bone marrow 
cells stained with F1 anti-Ig and F1 anti-~,  as the latter population of cells is 
reported to lack surface IgD. 
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